tiprankstipranks
Aridis Pharmaceuticals (ARDS)
OTHER OTC:ARDS
US Market

Aridis Pharmaceuticals (ARDS) Financial Statements

204 Followers

Aridis Pharmaceuticals Financial Overview

Aridis Pharmaceuticals's market cap is currently $4.46K. The company's EPS TTM is $; its P/E ratio is ―; Aridis Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Mar 22Dec 20Mar 20Dec 18
Income Statement
Total Revenue$ 0.00$ 0.00$ 1.00M$ 1.02M$ 2.76M
Gross Profit$ 0.00$ 0.00$ 1.00M$ 1.02M$ 2.76M
Operating Income$ -29.99M$ -43.71M$ -22.40M$ -29.09M$ -24.12M
EBITDA$ -29.51M$ -43.00M$ -22.06M$ -28.75M$ -23.83M
Net Income$ -30.75M$ -42.28M$ -22.33M$ -29.68M$ -22.11M
Balance Sheet
Cash & Short-Term Investments$ 4.88M$ 19.99M$ 8.23M$ 20.90M$ 24.24M
Total Assets$ 14.70M$ 26.80M$ 15.12M$ 27.97M$ 31.61M
Total Debt$ 6.13M$ 5.98M$ 715.00K$ 0.00$ 0.00
Net Debt$ 1.25M$ -14.01M$ -7.52M$ -20.90M$ -24.24M
Total Liabilities$ 38.93M$ 40.91M$ 23.80M$ 24.33M$ 5.30M
Stockholders' Equity$ -24.23M$ -13.11M$ -8.68M$ 3.64M$ 26.31M
Cash Flow
Free Cash Flow$ -29.21M$ -23.47M$ -20.84M$ -8.33M$ -24.95M
Operating Cash Flow$ -29.13M$ -22.94M$ -20.48M$ -8.16M$ -24.27M
Investing Cash Flow$ -82.00K$ -530.00K$ -367.00K$ -174.00K$ -1.68M
Financing Cash Flow$ 14.78M$ 34.72M$ 8.68M$ 4.99M$ 25.09M
Currency in USD

Aridis Pharmaceuticals Earnings and Revenue History

Aridis Pharmaceuticals Debt to Assets

Aridis Pharmaceuticals Cash Flow

Aridis Pharmaceuticals Forecast EPS vs Actual EPS